SYT1, synaptotagmin 1, 6857

N. diseases: 460; N. variants: 15
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0549473
Disease: Thyroid carcinoma
Thyroid carcinoma
0.060 PosttranslationalModification disease BEFREE Consistently, AXL stimulation with its ligand growth arrest-specific gene 6 (GAS6) increased AKT1- and p65 NF-kB-phosphorylation and promoted survival of thyroid cancer cell lines in culture. 31181609 2019
CUI: C0549473
Disease: Thyroid carcinoma
Thyroid carcinoma
0.060 Biomarker disease BEFREE Conclusion The levels of NF-κB p50 and NF-κB p65 in samples of thyroid carcinoma were positively associated with tumour diameter and the presence of lymph node metastasis. 30014762 2018
CUI: C0549473
Disease: Thyroid carcinoma
Thyroid carcinoma
0.060 Biomarker disease BEFREE Mechanistic studies have shown that cyclin D1 and p65 are important mediators in the processes, which provides a new way to study the mechanism of MMPs promoting the progression of thyroid cancer. 30171715 2018
CUI: C0549473
Disease: Thyroid carcinoma
Thyroid carcinoma
0.060 PosttranslationalModification disease BEFREE In this study, we found that melatonin showed potent suppressive roles on NF-κB signaling via inhibition of p65 phosphorylation and generated redox stress in thyroid cancer including the anaplastic subtypes. 29525603 2018
CUI: C0549473
Disease: Thyroid carcinoma
Thyroid carcinoma
0.060 Biomarker disease BEFREE We conclude that expression of C-ERBB2 and P65 genes is associated with follicular adenoma but not with cancer of thyroid gland. 12722795 2003
CUI: C0549473
Disease: Thyroid carcinoma
Thyroid carcinoma
0.060 AlteredExpression disease BEFREE Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. 9365245 1997